|Edwards Lifesciences Corporation -- USA Stock|| |
USD 115.57 2.61 2.21%
Corporate Vice President Critical Care
Ms. Catherine M. Szyman was Corporationrationrate Vice President, Critical Care of Edwards Lifesciences Corporationrationration since January 2015. Prior to 2015, she was employed for more than 20 years at Medtronic, Inc., where she served as its Senior Vice President and President of Medtronic global diabetes business from 2009 to 2014, overseeing research, development, operations, sales and marketing for Medtronic insulin infusion pumps and continuous glucose monitoring systems. Prior to that, she held a variety of leadership roles at Medtronic, including Senior Vice President of Global Channel Management and Corporationrationrate Strategy and Business Development, Vice President and General Manager of Endovascular Innovations and Vice President of Finance for the Vascular Business
Age: 49 President Since 2015 MBA
949 250-2500 www.edwards.com
Szyman previously served on the boards of Tornier, Inspire Medical Systems, and the California Healthcare Institute. She graduated from the University of St. Thomas, and earned her MBA from Harvard Business School.
Catherine Szyman Latest Insider Activity
The company has Return on Asset (ROA)
of 12.64 %
which means that for every $100 of asset it generated profit of $12.64. This is typical in the industry. Likewise, it shows return on total equity (ROE)
of 25.45 %
which means that it produced $25.45 on every 100 dollars invested by current stockholders.
The company reports 1.03 B of total liabilities with total debt to equity ratio (D/E) of 32.7 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 3.42 indicating that it is in good position to pay out its debt commitments in time.
Edwards Lifesciences Corporationration offer solutions and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences Corporation (EW) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 9,800 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.